MiMedx Group Stock Price and Value Analysis

Should you buy MiMedx Group stock? (Other OTC:MDXG). Let's see how it does in our automated value investing analysis system.

AdvantagesDisadvantagesNeutral
None.
  • This stock looks overpriced.
  • This company is not making money.
  • This company has wild ups and downs.
  • This company is less known than others.
  • This company pays no dividend.

Inside the MDXG Numbers

MDXG Price
(MiMedx Group stock price per share)
$6.94
[?] PE Ratio versus Sector 10% higher than other Healthcare stocks
[?] PE Ratio versus Industry 48% higher than other Medical Devices stocks
[?] Free Cash Flow Jitter 71%

Is MiMedx Group Stock on Sale?

Based on our analysis, we believe that you should not buy MiMedx Group right now. It might be a good stock to own—we just can't prove it with value analysis right now. Proceed with caution.

Should You Buy MDXG Stock?

Does MiMedx Group have a coherent story? Does it have a plan to continue to make money? Is it worth your time? Only you can decide where to go from here. Our investment guide helps you ask the right questions, including how to buy stocks. Use these research links for more information.